Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Misty Shields

Thoracic Oncology · IUSM

View

Dr. Gilberto Lopes

Thoracic Oncology · University of Miami

View

Dr. Jacob Sands

Thoracic Oncology · Dana-Farber Cancer Institute

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    MVDr. Maria Velez Velez

    Dr. Maria Velez Velez

    Medical Oncology · Thoracic Oncology
    UCLA Health
    mariavelezvelez

    Research

    Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1

    2026

    Via JCEM Case Reports

    Research

    Evaluating datopotamab deruxtecan (Dato-DXd) as a novel treatment option for EGFR-mutated non-small cell lung cancer

    2026

    Via Future Oncology

    Research

    Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer

    2025

    Via Chest

    Research

    Identification of Targetable Mutations in Ovarian Cancer

    2025

    Via JCO Precision Oncology

    Research

    Characteristics of clinical trials associated with appeal and return on investment to participants: a review and framework

    2025

    Via The Oncologist

    Research

    Differences in Clinical Trial Availability vs Distribution of Disease Among Gynecological Cancers

    2025

    Via Oncology (Williston Park)

    Research

    Expanding Lung Cancer Clinical Trial Criteria: A Systematic Review on Inclusion of Patients with Brain Metastases and Leptomeningeal Disease

    2025

    Via Clinical Lung Cancer

    Research

    Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy

    2025

    Via JCO Oncology Practice

    Research

    A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol

    2024

    Via BMC Cancer

    Research

    Is There a Place for Temozolomide plus Nivolumab among Neuroendocrine Neoplasms?

    2023

    Via Clinical Cancer Research

    Research

    Consent document translation expense hinders inclusive clinical trial enrolment

    2023

    Via Nature

    Research

    What is the current role of immunotherapy in EGFR mutant advanced NSCLC?

    2022

    Via Lung Cancer

    Research

    Severity of COVID-19 in patients with lung cancer: evidence and challenges

    2021

    Via Journal for Immunotherapy of Cancer

    Research

    Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC

    2021

    Via Lung Cancer